Johnson & Johnson Services, INC.
Global biopharmaceutical, medical device and consumer product manufacturer.
Based in DC
🤖
AI Overview
With $1.0M in lobbying spend across 21 quarterly filings, Johnson & Johnson Services, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2021 to 2025.
$1.0M
Total Spend
5
Years Active
1
Firms Hired
3
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $100K |
| 2022 | $250K |
| 2023 | $200K |
| 2024 | $250K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, Medicare/Medicaid, Law Enforcement
- •General health care issues in federal health programs; general federal budget and appropriations issues related to health care policy; general health care and public health issues
- •S. 2706, DIVERSE Trials Act; COVID-19 vaccinations
- •Value of prescription drugs
- •Issues related to Medicare Parts B & D
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
American Association of Child & Adolescent Psychiatry
$1.6M total spend
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
National Association of Children's Hospitals (N.a.c.h.)
$38.0M total spend
American Clinical Laboratory Assn
$23.9M total spend
National Association of Benefits and Insurance Professionals
$8.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.